ClearBridge Investments
BHVN icon

ClearBridge Investments’s Biohaven BHVN Stock Holding History

ClearBridge Investments’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-430,377
Closed -$6.46M – 704
2025
Q3 		$6.46M Sell
430,377
-78,664
-15% -$1.15M ﹤0.01% 570
2025
Q2 		$7.18M Sell
509,041
-1,783
-0.3% -$31.8K 0.01% 531
2025
Q1 		$12.3M Sell
510,824
-10,275
-2% -$362K 0.01% 461
2024
Q4 		$19.5M Buy
521,099
+41,850
+9% +$1.95M 0.02% 439
2024
Q3 		$23.9M Sell
479,249
-120
-0% -$4.67K 0.02% 422
2024
Q2 		$16.6M Buy
479,369
+69,180
+17% +$2.74M 0.01% 474
2024
Q1 		$22.4M Sell
410,189
-21,875
-5% -$1.08M 0.02% 445
2023
Q4 		$18.5M Buy
432,064
+91
+0% +$2.83K 0.02% 476
2023
Q3 		$11.2M Sell
431,973
-1,465
-0.3% -$30.4K 0.01% 498
2023
Q2 		$10.4M Buy
433,438
+1,819
+0.4% +$31.3K 0.01% 513
2023
Q1 		$5.9M Buy
431,619
+10,320
+2% +$164K 0.01% 541
2022
Q4 		$5.85M Buy
+421,299
New +$5.95M 0.01% 554

Other funds holding BHVN

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments's BHVN Position: Q4 2025 in Review

ClearBridge Investments sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 430,377 shares — an estimated $6.46M sold.

ClearBridge Investments first reported a position in BHVN in Q4 2022 and held it in 12 quarters. The position peaked at $23.9M in Q3 2024. 272 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • ClearBridge Investments reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
  • ClearBridge Investments sold 430,377 Biohaven shares in Q4 2025, an estimated $6.46M.
  • ClearBridge Investments first reported a position in Biohaven in Q4 2022 and held it in 12 quarters.
  • ClearBridge Investments's Biohaven position peaked at $23.9M in Q3 2024.
  • 272 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on ClearBridge Investments's 13F filing for Q4 2025, filed 11 Feb 2026.